BUFFALO, N.Y., June 18, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced the launch of an updated website emphasizing the Company’s broad oncology drug pipeline. The website address is: http://www.cbiolabs.com and the site incorporates interactive messaging and enhanced navigation.
